Clinical Infection Monitoring
Clinical Infection Monitoring - Related Videos
04:29
Monitoring Neutrophil Recruitment Dynamics and Bacterial Burden at the Infection Site in a Murine Model
0 Views •
2025
This video demonstrates in vivo imaging to study the neutrophil recruitment dynamics at an infection site in an immunocompromised, transgenic mouse with GFP-expressing neutrophils. It involves injecting luminescent bacteria to cause an infection. This leads to neutrophil recruitment to the infection site, whose tracking is done by imaging.
01:25
Endocarditis II: Clinical Features of Infective Endocarditis
0 Views •
2025
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
18:40
Combined In vivo Optical and µCT Imaging to Monitor Infection, Inflammation, and Bone Anatomy in an Orthopaedic Implant Infection in Mice
0 Views •
Cited by 19 •
2014
Combined optical and μCT imaging in a mouse model of orthopaedic implant infection, utilizing a bioluminescent engineered strain of Staphylococcus aureus, provided the capability to noninvasively and longitudinally monitor the dynamics of the bacterial infection, as well as the corresponding inflammatory response and anatomical changes in the bone.
02:20
Monitoring Bacterial Infection and Effector Protein Delivery in Plant Cells
0 Views •
2025
Source: Lee, H. et. al., Split Green Fluorescent Protein System to Visualize Effectors Delivered from Bacteria During Infection. J. Vis. Exp. (2018)This video demonstrates a method for monitoring bacterial infection and effector protein delivery in plant cells using split superfolder green fluorescent protein (sfGFP) complementation combined with confocal microscopy. The approach enables precise visualization of effector translocation into the host cell cytosol.
09:22
Monitoring Immune Cells Trafficking Fluorescent Prion Rods Hours after Intraperitoneal Infection
0 Views •
Cited by 6 •
2010
Here we describe a novel assay for monitoring prion uptake and trafficking by immune cells immediately following intraperitoneal inoculation by purifying and fluorescently labeling aggregated prion rods from infected brain material then monitoring their uptake and movement from the injection site and characterizing the cells mediating these events.
FAQs
Repeated assessments reveal whether a patient’s condition is improving, remaining stable, or worsening. A single examination or test may provide only a snapshot, whereas measurements collected over time show the direction of change. This time-based comparison helps clinicians recognize persistent infection, evaluate response to treatment, and identify deterioration that may require prompt clinical attention.
Each source contributes a different type of evidence. Clinical examinations assess the patient directly, vital signs show physiological changes, laboratory tests provide objective measurements, and microbiological cultures contribute information about infectious organisms. Infection-related biomarkers add another indicator of disease activity. Considering these findings together supports a more informed assessment than relying on any single result.
Monitoring can reveal changes that suggest infection is becoming more severe, including worsening clinical findings, abnormal vital signs, or laboratory evidence of deterioration. Tracking these indicators over time helps clinicians distinguish routine recovery from a potentially dangerous progression. This supports earlier recognition of complications such as sepsis or organ dysfunction and may prompt reassessment of treatment.
A monitoring workflow combines repeated clinical examinations with serial vital-sign measurements and, when appropriate, laboratory testing, microbiological cultures, and infection-related biomarkers. The resulting information is compared across successive assessments rather than interpreted in isolation. This approach creates an objective record of disease progression and treatment response that can support ongoing clinical decisions.
Changes in clinical findings, test results, cultures, and infection-related biomarkers can show whether treatment is producing the expected response. Clinicians use this evolving evidence to evaluate effectiveness and inform antimicrobial decisions, including selection and duration. Monitoring therefore helps align treatment with the patient’s course while identifying persistent or worsening infection that may require further evaluation.
In hospitals and other healthcare settings, structured monitoring supports patient safety and helps evaluate treatment effectiveness across the course of illness. Its findings can also inform infection-control decisions when patterns of infection or ongoing risk require attention. By providing objective, time-based information, the approach connects bedside assessment with broader clinical and healthcare-setting decisions.